Methods to Address Impurities in Generic Products such as Nitrosamines
This session will discuss what research is needed to develop efficient bioequivalence standards for products that are reformulated to mitigate potential risks of nitrosamines, such as elucidating excipient effects related to nitrosamine impurity formation, addressing potential concerns related to the mutagenicity or carcinogenicity of reactive impurities in certain drug products, and identifying other aspects of emerging issues related to nitrosamines.
4 Likes
Great topic to cover. Appreciate you getting the word out on this.
1 Like
2 Likes
Thanks a lot! 
It is very interesting!!
2 Likes